Medicine & Life Sciences

1. Glioma 100%
2. Fluorescence In Situ Hybridization 71%
3. Neoplasms 65%
4. Oligodendroglioma 45%
5. Glioblastoma 45%
6. Prostatic Neoplasms 43%
7. Astrocytoma 43%
8. Chromosomes 32%
9. Breast Neoplasms 30%
10. Cytogenetics 29%
11. Mutation 28%
12. Genes 26%
13. Loss of Heterozygosity 23%
14. Survival 22%
15. Trastuzumab 20%
16. Gene Amplification 19%
17. Cytogenetic Analysis 19%
18. Prostate 17%
19. Tumor Suppressor Genes 16%
20. Carcinoma 16%
21. Prostatectomy 16%
22. Single Nucleotide Polymorphism 15%
23. human ERBB2 protein 14%
24. Temozolomide 14%
25. Chromosome Aberrations 14%
26. Neoplasm Metastasis 13%
27. Genome-Wide Association Study 13%
28. Chromosomes, Human, Pair 8 13%
29. Prostatic Intraepithelial Neoplasia 13%
30. Comparative Genomic Hybridization 12%
31. Pathologists 12%
32. erbB-2 Genes 12%
33. Radiotherapy 12%
34. Ovarian Epithelial Carcinoma 12%
35. ErbB Receptors 12%
36. Chromosomes, Human, Pair 7 12%
37. Adenocarcinoma 11%
38. Therapeutics 11%
39. Chromosomes, Human, Pair 19 10%
40. Paraffin 10%
41. Brain Neoplasms 10%
42. Medulloblastoma 9%
43. Genome 9%
44. Microsatellite Repeats 9%
45. Isocitrate Dehydrogenase 9%
46. Molecular Biology 9%
47. Allelic Imbalance 9%
48. Immunohistochemistry 8%
49. Monosomy 1p Chromosome 1 8%
50. Telomere 8%